BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2053180)

  • 1. Histocompatibility profile of selected Latin American countries.
    Santiago-Delpín EA
    Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA in Singapore Chinese with rheumatoid arthritis.
    Boey ML; Wee GB; Mohan C; Howe HS; Chan SH; Feng PH
    J Rheumatol; 1992 Oct; 19(10):1517-9. PubMed ID: 1464861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behçet's disease and class II and III antigens of the major histocompatibility complex].
    Hamza M; Ayed K; Bardi R; Gorgi Y; Meddeb N
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):59-61. PubMed ID: 2320926
    [No Abstract]   [Full Text] [Related]  

  • 5. Genotyping analysis of HLA class II genes in donor-recipient kidney transplant pairs.
    Papola F; Canossi A; Valeri M; Romano P; Contasta I; Torlone N; Liberatore G; Piazza A; Di Rocco M; Maccarone D
    Transplant Proc; 1993 Dec; 25(6):3267-70. PubMed ID: 8266537
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term kidney graft outcome based on HLA-DRB1 matching.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi MO; Ohshima S; Ikoma F
    Transplant Proc; 1994 Aug; 26(4):1884-6. PubMed ID: 7915054
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 8. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.
    Thompson JS; Bryne JE; Hempel HO; Oldfather JW; Green WF; Crowe DO; Sanfilippo F; MacQueen JM; McCalmon RN; Tardiff GN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):251-4. PubMed ID: 8438290
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
    Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
    J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial HLA matching: its phase of impact on graft survival.
    Gilks WR; Bradley BA; Gore SM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):664-5. PubMed ID: 3274833
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposal for an International Registry and Depository of Hyperacute Rejection after kidney transplantation.
    Doxiadis II; Claas FH
    Transplant Proc; 1996 Feb; 28(1):225. PubMed ID: 8644190
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA antigen expression and panel reactive antibodies.
    Rodriguez L; Caldumbide I; Martinez L; Scagliotti P; Quiroga T
    Transplant Proc; 1995 Apr; 27(2):1811-2. PubMed ID: 7725514
    [No Abstract]   [Full Text] [Related]  

  • 13. The expression of major histocompatibility antigens on human articular chondrocytes.
    Lance EM; Kimura LH; Manibog CN
    Clin Orthop Relat Res; 1993 Jun; (291):266-82. PubMed ID: 7684959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serological class II typing with DNA-DR and DNA-DQ typing of kidney donors and recipients.
    Trejaut J; Dunckley H; Sullivan JS; Doran T; Chapman J
    Transplant Proc; 1990 Oct; 22(5):2133. PubMed ID: 1977223
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of HLA-A,B and DR antigens on cadaver kidney transplantation in the Japanese.
    Ohmori K; Yokoyama T; Kashiwabara H
    Transplant Proc; 1983 Dec; 15(4):2142-4. PubMed ID: 6369683
    [No Abstract]   [Full Text] [Related]  

  • 17. Crossmatch with donor skin: characterization of alloantibodies and correlation with early kidney rejection.
    Moraes JR; Moraes ME; Luo Y; Peters PC; Sagalowsky A; Dawidson I; Lu C; Stastny P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):471-2. PubMed ID: 1990588
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
    Momburg F; Koretz K; Von Herbay A; Möller P
    Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients.
    Claas FH; Gijbels Y; von Veen A; de Waal LP; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):665-6. PubMed ID: 2650216
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of flow cytometry cross-matching results on the outcome of cadaveric kidney transplantation.
    Wahlberg J; Bengtsson M; Bergström C; Gannedahl G; Festin R; Lewen G; Frödin L
    Transplant Proc; 1994 Jun; 26(3):1752-3. PubMed ID: 8030118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.